VDR and COVID-19: Currently, we have evidence of a deregulated vitamin D endocrine system in lung and immune cells of SARS‐CoV‐2‐infected patients.(128) Moreover, a recent study on systematic drug repurposing for COVID‐19 based on machine learning has found that, among others, the VDR protein could have a protector effect over pathways affected by the SARS‐CoV‐2 infection,(129) suggesting a potential protecting role for VDES metabolites such as cholecalciferol, calcifediol, or calcitriol.